These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12133003)

  • 1. Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11.
    Turriziani O; Schuetz JD; Focher F; Scagnolari C; Sampath J; Adachi M; Bambacioni F; Riva E; Antonelli G
    Biochem J; 2002 Nov; 368(Pt 1):325-32. PubMed ID: 12133003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of prolonged treatment with zidovudine, lamivudine, and abacavir on a T-lymphoblastoid cell line.
    Turriziani O; Pagnotti P; Pierangeli A; Focher F; Baranello C; Bellomi F; Falasca F; Morgan J; Schuetz JD; Antonelli G
    AIDS Res Hum Retroviruses; 2006 Oct; 22(10):960-7. PubMed ID: 17067265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance and drug combination features of the human immunodeficiency virus inhibitor, BCH-10652 [(+/-)-2'-deoxy-3'-oxa-4'-thiocytidine, dOTC].
    Taylor DL; Ahmed PS; Tyms AS; Wood LJ; Kelly LA; Chambers P; Clarke J; Bedard J; Bowlin TL; Rando RF
    Antivir Chem Chemother; 2000 Jul; 11(4):291-301. PubMed ID: 10950391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs.
    Schuetz JD; Connelly MC; Sun D; Paibir SG; Flynn PM; Srinivas RV; Kumar A; Fridland A
    Nat Med; 1999 Sep; 5(9):1048-51. PubMed ID: 10470083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolites.
    Paintsil E; Dutschman GE; Hu R; Grill SP; Wang CJ; Lam W; Li FY; Ghebremichael M; Northrup V; Cheng YC
    Antimicrob Agents Chemother; 2011 Feb; 55(2):895-903. PubMed ID: 21078952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.
    Gröschel B; Kaufmann A; Höver G; Cinatl J; Doerr HW; Noordhuis P; Loves WJ; Peters GJ; Cinatl J
    Biochem Pharmacol; 2002 Jul; 64(2):239-46. PubMed ID: 12123744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
    Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
    Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired resistance to chloroquine in human CEM T cells is mediated by multidrug resistance-associated protein 1 and provokes high levels of cross-resistance to glucocorticoids.
    Oerlemans R; van der Heijden J; Vink J; Dijkmans BA; Kaspers GJ; Lems WF; Scheffer GL; Ifergan I; Scheper RJ; Cloos J; Assaraf YG; Jansen G
    Arthritis Rheum; 2006 Feb; 54(2):557-68. PubMed ID: 16447232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of lamivudine [(-)-beta-L-2',3'-dideoxy-3'-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3.
    Minuesa G; Volk C; Molina-Arcas M; Gorboulev V; Erkizia I; Arndt P; Clotet B; Pastor-Anglada M; Koepsell H; Martinez-Picado J
    J Pharmacol Exp Ther; 2009 Apr; 329(1):252-61. PubMed ID: 19141712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cellular resistance to nucleoside reverse transcriptase inhibitors by the wild-type breast cancer resistance protein.
    Wang X; Nitanda T; Shi M; Okamoto M; Furukawa T; Sugimoto Y; Akiyama S; Baba M
    Biochem Pharmacol; 2004 Oct; 68(7):1363-70. PubMed ID: 15345326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the metabolism of beta-L-(-)-2',3'-dideoxy-3'-thiacytidine by thymidine, fludarabine, and nitrobenzylthioinosine.
    Rahn JJ; Kieller DM; Tyrrell DL; Gati WP
    Antimicrob Agents Chemother; 1997 May; 41(5):918-23. PubMed ID: 9145844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages.
    Jorajuria S; Dereuddre-Bosquet N; Becher F; Martin S; Porcheray F; Garrigues A; Mabondzo A; Benech H; Grassi J; Orlowski S; Dormont D; Clayette P
    Antivir Ther; 2004 Aug; 9(4):519-28. PubMed ID: 15456083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplacental drug transfer and frequency of Tk and Hprt lymphocyte mutants and peripheral blood micronuclei in mice treated transplacentally with zidovudine and lamivudine.
    Von Tungeln LS; Williams LD; Doerge DR; Shaddock JG; McGarrity LJ; Morris SM; Mittelstaedt RA; Heflich RH; Beland FA
    Environ Mol Mutagen; 2007; 48(3-4):258-69. PubMed ID: 16850453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of placental and fetal MDR transporters by chronic in utero exposure to NRTIs in Sprague-Dawley rats: Importance for fetoprotection.
    Minoia JM; Filia MF; Roma MI; De Fino FT; Copello GJ; Peroni RN
    Toxicol Appl Pharmacol; 2022 Sep; 450():116170. PubMed ID: 35843342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.
    Olivero OA; Tejera AM; Fernandez JJ; Taylor BJ; Das S; Divi RL; Poirier MC
    Mutagenesis; 2005 Mar; 20(2):139-46. PubMed ID: 15784690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of Tris-lipidation to modify drug cytotoxicity in multidrug resistant cells expressing P-glycoprotein or MRP1.
    Davey RA; Davey MW; Cullen KV; Wells XE; Francis CL; Williams HM; Yang Q; Moghaddam MJ; Widmer F; Whittaker RG
    Br J Pharmacol; 2002 Dec; 137(8):1280-6. PubMed ID: 12466237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytosine arabinoside (ara-C) resistance confers cross-resistance or collateral sensitivity to other classes of anti-leukemic drugs.
    Martin-Aragon S; Mukherjee SK; Taylor BJ; Ivy SP; Fu CH; Ardi VC; Avramis VI
    Anticancer Res; 2000; 20(1A):139-50. PubMed ID: 10769646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine.
    Peng XX; Shi Z; Damaraju VL; Huang XC; Kruh GD; Wu HC; Zhou Y; Tiwari A; Fu L; Cass CE; Chen ZS
    Leuk Res; 2008 May; 32(5):799-809. PubMed ID: 17996297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
    Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.